Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,768 | -3,584 | -2,400 | -1,127 | -27,234 |
| Depreciation Amortization | 87 | 60 | 37 | 18 | 72 |
| Other Working Capital | -718 | -570 | -477 | -224 | 3,069 |
| Other Operating Activity | 447 | 333 | 273 | 186 | 2,012 |
| Operating Cash Flow | $-4,952 | $-3,761 | $-2,567 | $-1,147 | $-22,081 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -6 | -3 | N/A | N/A |
| Other Investing Activity | -364 | -297 | -139 | -54 | -502 |
| Investing Cash Flow | $-371 | $-303 | $-142 | $-54 | $-502 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,394 | 6,394 | 6,013 | 289 | 4,999 |
| Financing Cash Flow | $6,394 | $6,394 | $6,013 | $289 | $4,999 |
| Beginning Cash Position | 1,886 | 1,886 | 1,886 | 1,886 | 19,470 |
| End Cash Position | 2,957 | 4,216 | 5,190 | 974 | 1,886 |
| Net Cash Flow | $1,071 | $2,330 | $3,304 | $-912 | $-17,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,952 | -3,761 | -2,567 | -1,147 | -22,081 |
| Capital Expenditure | -7 | -6 | -3 | N/A | N/A |
| Free Cash Flow | -4,959 | -3,767 | -2,570 | -1,147 | -22,081 |